Details of CPPsite entry with Sequence IRQRRRR |
Primary information | |
---|---|
PEPTIDE SEQUENCE | IRQRRRR |
CPPsite ID | 2168, 2487, |
PEPTIDE NAME | IRQ, IRQ |
CHIRALITY | L, L |
LINEAR/CYCLIC | Linear, Linear |
SOURCE | Synthetic, Synthetic |
CATEGORY | Cationic, NA |
SUB CELLULAR LOCALIZATION | NA, NA |
N-TERMINAL MODIFICATION | Free, Free |
C-TERMINAL MODIFICATION | Free, Conjugation to solid lipid nanoparticle |
CHEMICAL MODIFICATION | Coupling to polyoxyethylene (40) steartae (SA-PEG2000), NA |
UPTAKE EFFICIENCY | IRQ modified SLNs showed better drug protection ability, Showed significantly higher drug internalization than that of unmodified ones |
PROPOSED UPTAKE MECHANISM | Clathrin- and caveolae-dependent endocytosis, Both clathrin- and caveolae-dependent endocytosis |
INVITRO/INVIVO | In vitro and in vivo, In vitro and in vivo |
CELL LINE | Caco-2/HT29-MTX, Caco-2 cells and goblet like HT29-MTX cells |
In VIVO MODEL | Male Sprague-Dawley rats, Male Sprague-Dawley rats |
CARGO | Nanoparticle [salmon calcitonin (sCT)-loaded SLNs (Solid Lipid Nanoparticle)], Protein (FITC-sCT), Nanoparticle( SLN) |
PMID | 24968819, 24968819 |
PATENT | Unknown, Unknown |
Tertiary Structure (Technique) | 2168 (PEPstrMOD), 2487 (PEPstrMOD), |